|
John Weidenbruch has served as the executive vice president and general counsel at Idenix since September 2006. Prior to joining Idenix Weidenbruch served as general counsel at Abraxis BioScience Inc. where he was responsible for all legal aspects of the company including regulatory corporate and commercialization activities. Prior to joining Abraxis Weidenbruch worked at Amgen Inc. for more than ten years where he held positions of increasing responsibility including senior director of law operations and senior associate general counsel of global commercial operations leading a team of attorneys that along with day-to-day guidance for commercial activities supported the launch of new products. Weidenbruch also served as the assistant general counsel and director of state government relations for the Nonprescription Drug Manufacturers Association where he directed the association’s legislative representation before all fifty state legislatures boards of pharmacy and regulatory bodies Weidenbruch holds a B.A. from Loyola College in Baltimore Maryland and a J.D. from Georgetown University Law Center in Washington D.C. | 